Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mohammed Mansour Alshehri has a total of 255 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Computational Characterization of Ceftriaxone and Novel Compounds in Opioid Use Disorder: Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulations

    by Rawan S. Alsikhan, Faizul Azam, Mohammed M. Alshehri, Qamraa H. Alqahtani, Hala H. Alrefashy, Sarah T. Binakeel, Abdullah F. AlAsmari, Youssef Sari, Wayne E. Childers, Magid Abou-Gharbia, et al.

    Opioid use disorder (OUD) is a global issue characterized by compulsive opioid use and is linked to significant morbidity and mortality. Ceftriaxone has been investigated for its potential neuroprotective and immunomodulatory effects; however, its mechanisms in opioid dependence remain unclear. This study employed a network pharmacological approach to explore the potential molecular target of ceftriaxone and related signaling pathways in OUD. Targets were identified based on a comparative toxicogenomics database, SwissTargetPrediction, complemented by PharmMapper for ceftriaxone and GeneCards and Gene Expression Omnibus for OUD. Overlapping targets were identified using Venn diagrams and analyzed via the STRING platform to construct a protein–protein interaction network. Biological insights were sourced from the DAVID database, and Gene Ontology and KEGG pathway enrichment evaluated the biological significance of the target genes using Metascape. Molecular docking was performed using AutoDock Vina (version 1.1.1) for ceftriaxone, its analogs, and other GLT-1 modulators: MC-100093, MC-350012, MC-350013, and MC-290401. A total of 10 overlapping genes (IL-1β, TNF, ALB, EGFR, ESR1, CDK5, MME, SLC1A2, EPO, and SRC) were identified with multiple biological functions and signaling pathways. Molecular docking predicted that the novel GLT-1 modulator, MC-350013, exhibited favorable docking scores toward several prioritized proteins, particularly ESR1, EGFR, IL-1β, and ALB. Molecule 13 also demonstrated favorable docking scores for the selected proteins. Molecular dynamics simulations characterized the interaction behavior of the novel GLT-1 modulator, MC-350012 and MC-350013. Although ceftriaxone showed stronger hydrogen-bonding interactions, MC-350012 and MC-350013 showed favorable predicted interaction profiles with IL-1β and ESR1. Collectively, these computational findings may suggest MC-350012 and MC-350013 as candidates for further experimental investigation based on their predicted interactions with key OUD-related targets.

  • Open Access

    Multi-Source Transcriptomic and Structural Prioritization of Adansonia digitata Phytochemicals in Myocardial Infarction

    by Loulwah Alothman, Alaa Alnoor Alameen, Mohammed M. Alshehri, Ejlal Mohamed Abdullah, Hala Aldahshan, Marwah Mohammed Alsamhari, Mougina K. Eltahir

    Background/Objectives: Myocardial infarction (MI) remains a major therapeutic challenge, and the molecular targets potentially associated with the cardiovascular activity of Adansonia digitata phytochemicals remain incompletely characterized. This study integrated phytochemical, transcriptomic, disease-gene, network, and structural evidence to prioritize candidate phytochemical–MI target associations. Methods: Ten polyphenols were selected from published LC-MS/QTOF data. Targets predicted using SwissTargetPrediction and PharmMapper were integrated with MI-associated evidence from the GSE66360 (circulating endothelial cell), GSE325257 (cardiac targeted gene-expression), and DisGeNET. An initial composite analysis generated a 19-gene discovery module for network and structural prioritization. A complementary source-resolved sensitivity analysis independently evaluated the three MI evidence sources. Selected interactions were examined by molecular docking, 200 ns molecular dynamics simulations, and MM/PBSA binding free-energy estimation. Results: Sensitivity analysis identified 189 genes supported by at least two MI evidence sources, including 21 predicted Adansonia digitata targets. Four genes (GSK3B, NOS3, SOD2, and TGFBR1) were shared between the 19-gene discovery and 21-gene sensitivity modules. Gene Ontology analysis identified 36 significantly overrepresented biological-process terms (FDR < 0.05). Docking supported the selection of chlorogenic acid and rutin for simulation with MMP2 and NOS3. MM/PBSA calculations indicated that chlorogenic acid exhibited more favorable estimated binding energies compared to rutin, especially in the case of MMP2. However, these differences were not statistically validated. Conclusions: The complementary integration strategies prioritized candidate Adansonia digitata phytochemicals and MI-associated targets and generated testable hypotheses for further investigation. These computational findings are hypothesis-generating and require experimental validation of target engagement, biological activity, pharmacokinetics, and efficacy in MI models.

  • In Silico Exploration of Anti‐Cancer Phytochemicals as Novel Inhibitors of LRRK2 via the WDR Domain

    by Haruna Isiyaku Umar, Mohammed M. Alshehri, Marwa Alaqarbeh, Omoboyede Victor, Temitayo Abidat Hassan, Ridwan Opeyemi Bello, Abdul‐Raheem Folorunsho Ahmad, Ismail Kolawole Odetayo, Ahmed F. Alanazi, Yousef Saeed Alqarni, et al.

    LRRK2 serves as a significant oncogenic driver in multiple malignancies, including glioblastoma, lung, breast, and ovarian cancers. It enhances cancer cell growth, metastasis, and survival by modulating critical signaling pathways, including MET, p53, and JNK. The WD40‐repeat (WDR) domain of LRRK2 is a crucial protein–protein interaction region required for regulating oncogenic signaling pathways. The current research examines the inhibitory ability of 104 phytochemicals obtained from anticancer plants against the WDR domain of LRRK2 through in silico experiments that include drug‐likeness, molecular docking, molecular dynamics simulations, and ADMET profiling. Ellagic acid and cucurbitacin B exhibited enhanced binding affinities (−9.58 and −8.46 kcal/mol, respectively) compared to the reference compound MLi‐2‐NC (−3.16 kcal/mol). Both compounds showed no ability to block the hERG channel, were non‐mutagenic, and had moderate intestinal absorption. Molecular dynamics simulations indicated durable binding interactions, with cucurbitacin B displaying the strongest binding free energy (−25.69 kcal/mol) and persistent protein–ligand interactions, whereas ellagic acid exhibited consistent but comparatively weaker interactions (−11.84 kcal/mol). Here, ellagic acid and cucurbitacin B are identified as promising for further development as agents that can modulate LRRK2‐driven carcinogenic pathways. These findings offer compelling justification for experimental validation.


  • Open Access

    Ceftriaxone and MC-100093 mitigate fentanyl-induced cardiac injury in mice: Preclinical investigation of its underlying molecular mechanisms

    by Abdullah F. AlAsmari, Mohammed M. Alshehri, Nemat Ali, Fawaz AlAsmari, Youssef Sari, Wayne E. Childers, Magid Abou-Gharbia, Metab Alharbi, Doaa M. Elnagar, Wejdan S. Al-Qahtani


  • The Neuropharmacological Potential of Piperazine Derivatives: A Mini- Review

    by Saad Alghamdi, Mohammed M. Alshehri, Mohammad Asif

    Piperazine is a six-membered heterocyclic ring with two nitrogen atoms at positions one and four. This piperazine moiety can be present in a slew of well-known medicines that have pharmacophoric effects on a variety of receptors. Various piperazine analogs have core biological activities involving the activation of monoamine pathways, primarily on neurotransmitter receptors. As a result, piperazine analogs have a wide range of central clinical uses, including anxiolytic, antipsychotic, and antidepressant. Due to its stimulant and euphoric effects, benzyl-piperazine is the prototype of piperazine analogs, and this molecule is the main substance of recreational drugs. This review focused on the activity of piperazine pharmacophore on diverse neurotransmitter receptors and used therapeutically as an anxiolytic (buspirone), an antidepressant (vortioxetine), antipsychotics (clozapine), and other drugs.


  • Open Access

    Discovery of Novel HSP27 Inhibitors as Prospective Anti-Cancer Agents Utilizing Computer-Assisted Therapeutic Discovery Approaches

    by Haruna Isiyaku Umar, Adeola Temitayo Ajayi, Nobendu Mukerjee, Abdullahi Tunde Aborode, Mohammad Mehedi Hasan, Swastika Maitra, Ridwan O. Bello, Hafsat O. Alabere, Afees A. Sanusi, Olamide O. Awolaja, et al.

    Heat shock protein 27 (HSP27) is a protein that works as a chaperone and an antioxidant and is activated by heat shock, environmental stress, and pathophysiological stress. However, HSP27 dysregulation is a characteristic of many human cancers. HSP27 suppresses apoptosis and cytoskeletal reorganization. As a result, it is recognized as a critical therapeutic target for effective cancer therapy. Despite the effectiveness of multiple HSP27 inhibitors in pre-clinical investigations and clinical trials, no HSP27 inhibitor has progressed to the anticancer phase of the development. These difficulties have mostly been attributable to existing anticancer therapies’ inability to target oncogenic HSP27. Highly selective HSP27 inhibitors with higher effective-ness and low toxicity led to the development of combination techniques that include computer-aided assisted therapeutic discovery and design. This study emphasizes the most recent results and roles of HSP27 in cancer and the potential for utilizing an anticancer chemical database to uncover novel compounds to inhibit HSP27.


  • Open Access

    Evaluation of mutagenesis, necrosis and apoptosis induced by omeprazole in stomach cells of patients with gastritis

    by Ana Maria Oliveira Ferreira da Mata, Marcia Fernanda Correia Jardim Paz, Ag-Anne Pereira Melo de Menezes, Antonielly Campinho dos Reis, Bruna da Silva Souza, Carlos Dimas de Carvalho Sousa, Sônia Alves Machado, Thiago Soares Gondim Medeiros, Chandan Sarkar, Muhammad Torequl Islam, et al.

    Background: Gastritis is a superficial and prevalent inflammatory lesion that is considered a public health concern once can cause gastric ulcers and gastric cancer, especially when associated with Helicobacter pylori infection. Proton pump inhibitors, such as omeprazole, are the most widely used drugs to treat this illness. The aim of the study was evaluate cytogenetic effects of omeprazole in stomach epithelial cells of patients with gastritis in presence and absence of H. pylori, through cytogenetic biomarkers and catalse and superoxide dismutase analysis. Methods: The study included 152 patients from the Gastroenterology Outpatient Clinic of Hospital Getúlio Vargas, Teresina—Brazil, that reported continuous and prolonged omeprazole use in doses of 20, 30 and 40 mg/kg. The participants were divided into groups: (1) patients without gastritis (n = 32); (2) patients without gastritis but with OME use (n = 24); (3) patients with gastritis (n = 26); (4) patients with gastritis undergoing OME therapy (n = 26); (5) patients with gastritis and H. pylori (n = 22) and (6) patients with gastritis and H. pylori on OME therapy (n = 22). Results: OME induced cytogenetic imbalance in the stomach epithelium through the formation of micronuclei (group 6 > 1, 2, 3, 4, 5; group 5 > 1, 2, 3; group 4 > 1, 2, 3); bridges (groups 4 and 6 > 1, 2, 3, 5 and group 2 > 3, 5); buds (groups 2,4,6 > , 1, 3, 5); binucleated cells (group 6 > 1, 2, 3, 4, 5; group 4 > 1, 2, 3); (groups 2 and 3 > 1); picnoses (group 6 > 1, 2, 3, 4, 5), groups 2 and 5 > 1, 3; group 4 > 1, 2, 3, 5); cariorrexis (groups 6 and 4 > 1, 2, 3, 5; groups 2, 3, 5 > 1) and karyolysis (groups 2, 4, and 6 > 1, 3, 5; groups 3 and 5 > 1). The OME cytogenetic instability was associated with H. pylori infection, indicating clastogenic/aneugenic effects, chromosomes alterations, gene expression changes, cytotoxicity and apoptosis. Conclusions: The cytogenetic changescan be attributed to several mechanisms that are still unclear, including oxidative damage, as observed by increased catalase and superoxide dismutase expresion. Positive correlations between antioxidant enzymes were found with micronuclei formation, and were negative for picnoses. Thus, the continuous and prolonged omeprazole use induces genetic instability, which can be monitored through cytogenetic analyzes, as precursor for gastric cancer.


  • Open Access

    Urtica dioica-Derived Phytochemicals for Pharmacological and Therapeutic Applications

    by Yasaman Taheri, Cristina Quispe, Jesús Herrera-Bravo, Javad Sharifi-Rad, Shahira M. Ezzat, Rana M. Merghany, Shabnum Shaheen, Lubna Azmi, Abhay Prakash Mishra, Bilge Sener, et al.

    Urtica dioica belongs to the Urticaceae family and is found in many countries around the world. This plant contains a broad range of phytochemicals, such as phenolic compounds, sterols, fatty acids, alkaloids, terpenoids, flavonoids, and lignans, that have been widely reported for their excellent pharmacological activities, including antiviral, antimicrobial, antihelmintic, anticancer, nephroprotective, hepatoprotective, cardioprotective, antiarthritis, antidiabetic, antiendometriosis, antioxidant, anti-inflammatory, and antiaging effects. In this regard, this review highlights fresh insight into the medicinal use, chemical composition, pharmacological properties, and safety profile of U. dioica to guide future works to thoroughly estimate their clinical value.


  • Open Access

    Nutraceutical Profiling, Bioactive Composition, and Biological Applications of Lepidium sativum L.

    by Sakshi Painuli, Cristina Quispe, Jesús Herrera-Bravo, Prabhakar Semwal, Miquel Martorell, Zainab M. Almarhoon, Ainur Seilkhan, Alibek Ydyrys, Javad Sharifi Rad, Mohammed M. Alshehri, et al.

    The roots, leaves, and seeds of Lepidium sativum L., popularly known as Garden cress in different regions, have high economic importance; although, the crop is particularly cultivated for the seeds. In traditional medicine, this plant has been reported to possess various biological activities. This review is aimed at providing updated and critical scientific information about the traditional, nutritional, phytochemical, and biological activities of L. sativum. In addition, the geographic distribution is also reviewed. The comprehensive literature search was carried out with the help of different search engines PubMed, Web of Science, and Science Direct. This review highlighted the importance of L. sativum as an edible herb that possesses a wide range of therapeutic properties along with high nutritional values. Preclinical studies (in vitro and in vivo) displayed anticancer, hepatoprotective, antidiabetic, hypoglycemic, antioxidant, antimicrobial, gastrointestinal, and fracture/bone healing activities of L. sativum and support the clinical importance of plant‐derived bioactive compounds for the treatment of different diseases. Screening of literature revealed that L. sativum species and their bioactive compounds may be a significant source for new drug compounds and also could be used against malnutrition. Further clinical trials are needed to effectively assess the actual potential of the species and its bioactive compounds.


  • Open Access

    Hyssopus Essential Oil: An Update of Its Phytochemistry, Biological Activities, and Safety Profile

    by Javad Sharifi-Rad, Cristina Quispe, Manoj Kumar, Muhammad Akram, Mewish Amin, Mehwish Iqbal, Niranjan Koirala, Oksana Sytar, Dorota Kregiel, Silvana Nicola, et al.

    The genus Hyssopus is widespread in central Asia, East Mediterranean, and Mongolian areas. It has six main species which are used as herbal remedies, such as Hyssopus officinalis which is used as a condiment and flavoring agent in food industry. The other five species are H. ambiguus, H. cuspidatus, H. latilabiatus, H. macranthus, and H. seravschanicus. Its species are used in the treatment of various ailments such as cold, cough, loss of appetite, fungal infection, and spasmodic condition. Its constituents especially essential oils are popularly used as an additive in beverages, foods, and cosmetics. The volatile constituents are used for aroma in the food industry, cosmetic industry, and household products. The important active constituents in its essential oils are β‐pinene, pinocamphone, isopinocamphone, and other terpenoids. Hyssopus genus is also bundled with other secondary metabolites including flavonoids luteolin, quercetin, apigenin, and their glucosides, as well as phenolic compounds including ferulic, p‐hydroxy‐benzoic acid, protocatechuic acid, chlorogenic, and caffeic acid. Combinedly, the extracts of Hyssopus are reported to have potential antiviral and antifungal activities proven using in vitro studies, whereas in vivo investigations have reported the crucial role of Hyssopus extracts in plasma membrane relaxation, cytotoxic, and sedative effects. This plant is believed to be relatively safe at levels commonly used in foods; nevertheless, more studies are needed to determine the safety profile.